Ingredion Incorporated (INGR) Earnings Call Transcripts

46 earnings calls from February 2020 to August 4, 2026

NYSE US Consumer Staples Food Products

Ingredion Incorporated's Latest Earnings Call - June 8, 2026

In the second quarter of fiscal year 2026, Ingredion Incorporated announced a significant acquisition of Tate & Lyle, which is expected to transform the company into a global leader in ingredient solutions. The acquisition is valued at approximately $5 billion, with Tate & Lyle generating $2.7 billion in revenue and $570 million in adjusted EBITDA for the fiscal year. Management expects the combined entity to achieve $10 billion in revenue and an adjusted EBITDA margin of 18.1%, with a projected run rate net cost synergy opportunity of $130 million by 2030, signaling a strong growth trajectory and enhanced operational efficiency.

Reported metrics

MetricValueContext
Revenue $10B (positive) expected combined revenue post-acquisition
Adjusted EBITDA $1.8B (positive) expected combined adjusted EBITDA post-acquisition
Adjusted EBITDA Margin 18.1% (positive) expected margin prior to integration and synergies
Acquisition Value $5B (positive) total enterprise value for Tate & Lyle
Cost Synergies $130M (positive) expected annual run rate net cost synergies by 2030
One-time Cash Costs $175M (negative) costs to achieve synergies

Guidance from management

Management expects the acquisition to be more than 15% accretive to adjusted EPS in the first full calendar year following the acquisition, with improved free cash flow conversion.

What management said

And the only thing that I would add to what Jason said is that, again, everything that we've identified are run rate cost synergies, and we have not factored in any revenue synergies.
— James Zallie, June 8, 2026 earnings call
And to your point about potential upside, obviously, as this is what we've identified in the initial phases of the work. So as we continue to move forward with the integration, we'll obviously be looking for other opportunities to identify additional.
— Jason Payant, June 8, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the regulatory approval process and potential overlap issues. There were questions about the trajectory of Tate & Lyle's business fundamentals and how the integration might affect financial metrics in the near term.

Main topics on the call

Read the full Ingredion Incorporated transcript (June 8, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Ingredion Incorporated

Ingredion Incorporated (INGR) is a publicly listed company in the Food Products industry, within the Consumer Staples sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 46 calls on record spanning February 11, 2020 to August 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 46 Ingredion Incorporated earnings call transcripts on record, spanning February 11, 2020 to August 4, 2026. Based on this history, Ingredion Incorporated reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
INGR
Exchange
NYSE
Country
US
Sector
Consumer Staples
Industry
Food Products
Calls on record
46
First call
February 11, 2020
Most recent
August 4, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 4, 2026 Read transcript
M&A Calls Jun 8, 2026 Read transcript
Q1 FY2026 May 5, 2026 Read transcript
Company Conference Presentations Feb 17, 2026 Read transcript
Q4 FY2025 Feb 3, 2026 Read transcript
Q3 FY2025 Nov 4, 2025 Read transcript
Analyst/Investor Day Sep 17, 2025 Read transcript
Q2 FY2025 Aug 1, 2025 Read transcript
Company Conference Presentations Feb 18, 2025 Read transcript
Q4 FY2024 Feb 4, 2025 Read transcript
Q3 FY2024 Nov 5, 2024 Read transcript
Q2 FY2024 Aug 6, 2024 Read transcript
Company Conference Presentations May 16, 2024 Read transcript
Q1 FY2024 May 8, 2024 Read transcript
Company Conference Presentations Feb 21, 2024 Read transcript
Q4 FY2023 Feb 6, 2024 Read transcript
Q3 FY2023 Nov 7, 2023 Read transcript
Company Conference Presentations Sep 5, 2023 Read transcript
Q2 FY2023 Aug 8, 2023 Read transcript
Company Conference Presentations May 17, 2023 Read transcript
Q1 FY2023 May 3, 2023 Read transcript
Company Conference Presentations Feb 22, 2023 Read transcript
Q4 FY2022 Feb 8, 2023 Read transcript
Q3 FY2022 Nov 3, 2022 Read transcript
Q2 FY2022 Aug 9, 2022 Read transcript
Analyst/Investor Day Jun 2, 2022 Read transcript
Company Conference Presentations May 18, 2022 Read transcript
Q1 FY2022 May 5, 2022 Read transcript
Company Conference Presentations Feb 23, 2022 Read transcript
Q4 FY2021 Feb 3, 2022 Read transcript
Q3 FY2021 Nov 2, 2021 Read transcript
Q2 FY2021 Aug 3, 2021 Read transcript
Company Conference Presentations May 20, 2021 Read transcript
Shareholder/Analyst Calls May 19, 2021 Read transcript
Company Conference Presentations May 18, 2021 Read transcript
Q1 FY2021 May 4, 2021 Read transcript
Company Conference Presentations Feb 16, 2021 Read transcript
Q4 FY2020 Feb 3, 2021 Read transcript
Company Conference Presentations Dec 9, 2020 Read transcript
Q3 FY2020 Nov 2, 2020 Read transcript
Q2 FY2020 Aug 4, 2020 Read transcript
Shareholder/Analyst Calls May 20, 2020 Read transcript
Company Conference Presentations May 13, 2020 Read transcript
Q1 FY2020 May 5, 2020 Read transcript
Company Conference Presentations Feb 18, 2020 Read transcript
Q4 FY2019 Feb 11, 2020 Read transcript